View Author
patient tumor somatostatin treatment therapy study receptor imaging neuroendocrine response peptide cancer liver radionuclide lu-dota analog disease octreotide month tumours neuroendocrine tumors result lesion kwekkeboom analogue journal uptake medicine marrow level in-dtpa scintigraphy bone marrow krenning metastase radiolabeled effect group krenning ep bakker wh lu-octreotate european journal oncol survival 177 lu-octreotate tumour jong m carcinoid metastatic radiolabeled somatostatin analogs table gepnet 177 lu-dotatate toxicity carcinoma af finity kidney comparison lu-dotatate thyroid bone lesions signi phase combination kooij pp y-dotatoc european insulinoma trial 90 y-dotatoc kwekkeboom dj bone metastases y-dota valkema pancreatic follow-up phase ii study somatostatin receptor scintigraphy cycle endocrinol
10 Most Recent Publications
|
Peptide receptor radionuclide therapy (PRRT) for GEP-NETs
(Article)
Bergsma, H. Vliet, E.I. van Teunissen, J.J.M. Kam, B.L. Herder, W.W. de Peeters, R.P. Krenning, E.P. Kwekkeboom, D. |
2012-12-01
|
|
Tumor response assessment to treatment with [
177Lu-DOTA
0,Tyr
3]octreotate in patients with gastroenteropancreatic and bronchial neuroendocrine tumors: Differential response of bone versus soft-tissue lesions
(Article)
Vliet, E.I. van Hermans, J.J. Ridder, M.A.J. de Teunissen, J.J.M. Kam, B.L. Krijger, R.R. de Krenning, E.P. Kwekkeboom, D. |
2012-09-01
|
|
Treatment of Gastroenteropancreatic Neuroendocrine Tumors with Peptide Receptor Radionuclide Therapy
(Article)
Vliet, E.I. van Teunissen, J.J.M. Kam, B.L. Jong, M. de Krenning, E.P. Kwekkeboom, D. |
2012-01-10
|
|
Improved control of severe hypoglycemia in patients with malignant insulinomas by peptide receptor radionuclide therapy
(Article)
Schaik, E. van Vliet, E.I. van Herder, W.W. de Feelders, R.A. Krenning, E.P. Khan, S. Kamp, K. Valkema, R. Nederveen, F.H. van Teunissen, J.J.M. Kwekkeboom, D.J. |
2011-11-01
|
|
Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours
(Article)
Teunissen, J.J.M. Kwekkeboom, D.J. Valkema, R. Krenning, E.P. |
2011-10-01
|
|
Quality of life in 265 patients with gastroenteropancreatic or bronchial neuroendocrine tumors treated with [
177Lu-DOTA
0,Tyr
3]octreotate
(Article)
Khan, S. Krenning, E.P. Essen, M. van Kam, B.L. Teunissen, J.J.M. Kwekkeboom, D.J. |
2011-09-01
|
|
Preclinical and Clinical Studies of Peptide Receptor Radionuclide Therapy
(Article)
Pool, S.E. Krenning, E.P. Koning, G.A. Eijck, C.H.J. van Teunissen, J.J.M. Kam, B.L. Valkema, R. Kwekkeboom, D. Jong, M. de |
2010-05-01
|
|
Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
(Article)
Kwekkeboom, D.J. Kam, B.L. Essen, M. van Teunissen, J.J.M. Eijck, C.H.J. van Valkema, R. Jong, M. de Herder, W.W. de Krenning, E.P. |
2010-03-01
|
|
Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors
(Article)
Kwekkeboom, D. Herder, W.W. de Eijck, C.H.J. van Kam, B.L. Essen, M. van Teunissen, J.J.M. Krenning, E.P. |
2010-03-01
|
|
Bone marrow dosimetry in peptide receptor radionuclide therapy with [ 177Lu-DOTA0,Tyr3]octreotate
(Article)
Forrer, F. Krenning, E.P. Kwekkeboom, D. Kooij, P.P.M. Bernard, B.F. Konijnenberg, M. Bakker, W.H. Teunissen, J.J.M. Jong, M. de Lom, K. van Herder, W.W. de |
2009-07-01
|
